Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cardiovascular Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Older Patients in Routine Clinical Care With or Without History of Atherosclerotic Cardiovascular Diseases or Heart Failure.
Htoo PT, Buse J, Cavender M, Wang T, Pate V, Edwards J, Stürmer T. Htoo PT, et al. J Am Heart Assoc. 2022 Feb 15;11(4):e022376. doi: 10.1161/JAHA.121.022376. Epub 2022 Feb 8. J Am Heart Assoc. 2022. PMID: 35132865 Free PMC article.
Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease.
Patorno E, Htoo PT, Glynn RJ, Schneeweiss S, Wexler DJ, Pawar A, Bessette LG, Chin K, Everett BM, Kim SC. Patorno E, et al. Among authors: htoo pt. Ann Intern Med. 2021 Nov;174(11):1528-1541. doi: 10.7326/M21-0893. Epub 2021 Sep 28. Ann Intern Med. 2021. PMID: 34570599 Free PMC article.
Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease.
Patorno E, Htoo PT, Glynn RJ, Schneeweiss S, Wexler DJ, Pawar A, Bessette LG, Chin K, Everett BM, Kim SC. Patorno E, et al. Among authors: htoo pt. Ann Intern Med. 2022 Jan;175(1):W4-W5. doi: 10.7326/L21-0709. Ann Intern Med. 2022. PMID: 35038404 No abstract available.
21 results